2026-03-21 2026-03-21 , online online, 1,990 € zzgl. MwSt. Pharmaceutical Marketing Authorisation and Market Access in the Middle East: GCC and National Markets

This online event offers a comprehensive overview of marketing authorisation and market access in the Middle East, covering key topics like market entry, intellectual property, lifecycle management, pharmacovigilance and quality considerations, with a focus on Gulf Cooperation Council, Saudi Arabia, the UAE, Jordan and Syria.

Themen
  • Pharmaceutical marketing authorisation and market access in the GCC and key national markets
  • Intellectual property: Patents, data protection and regulatory considerations
  • Fast-track pathways, distribution strategies and legal frameworks
  • Dossier assessment, submission processes and compliance essentials
  • Key quality and production requirements for market entry
  • Import regulations, pharmacovigilance obligations and post-approval maintenance


Who should attend
This seminar is suitable for:
  • Regulatory affairs professionals in the pharmaceutical and healthcare industries
  • Market access and business development managers focusing on the Middle East region
  • Quality assurance and production specialists involved in regulatory compliance
  • Legal and intellectual property experts in the pharmaceutical sector

Participants should have a basic understanding of pharmaceutical regulatory frameworks and market access processes.
Ziel der Veranstaltung
This online training provides you with a comprehensive understanding of marketing authorisation and market access in the Middle East region, focusing on both GCC-wide and national regulatory frameworks. Through expert-led presentations and interactive discussions, you will gain in-depth knowledge of key topics such as market entry strategies, intellectual property, product classification, pricing regulations and distribution models. The event also covers legal frameworks and lifecycle management, including dossier assessments, eCTD submissions and import regulations. Additionally, it explores pharmacovigilance requirements, post-approval maintenance and quality considerations, with a particular focus on Saudi Arabia, the UAE, Jordan, and Syria.

There will be ample opportunity for individual questions, with experts on hand to provide tailored insights and guidance.
Teilnehmerkreis

  • Gain a clear overview of marketing authorisation pathways across the Middle East.
  • Develop a targeted authorisation strategy by assessing regulatory requirements and market conditions.
  • Deepen your understanding of quality, production, import regulations and eCTD dossier submissions.
Benefit from expert insights into intellectual property, pricing regulations and pharmacovigilance.
Connect with industry professionals to exchange experiences and best practices.

Marketing-Authorisation-and-Market-Access-in-the-Middle-East

Pharmaceutical Marketing Authorisation and Market Access in the Middle East: GCC and National Markets

Connect with regional experts from the Middle East in this exclusive online training!

Benefits
  • Excellent local experts
  • Networking with industry professionals
  • Targeted regulatory and market strategy
  • Officially certified according to ISO 9001 and ISO 21001

Webcode 26042510

Jetzt buchen

JETZT Buchen

Alles auf einen Blick

Termin

28 - 29/04/2026

28 - 29/04/2026

Zeitraum

Day 1: 9:00 am - 5:00 pm
Day 2: 9:00 am - 5:00 pm

Day 1: 9:00 am - 5:00 pm
Day 2: 9:00 am - 5:00 pm
Veranstaltungsort

online

online

Downloads
PROSPEKT
PROSPEKT
Gebühr

Event - 1,990€ plus tax
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.

Event - 1,990€ plus tax
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.

Inhouse-Angebote
Inhouse-Angebot anfordern
Inhouse-Angebot anfordern

Jetzt buchen

Your contact

Verena Planitz
Conference Manager

+49 6221 500-655
v.planitz@forum-institut.de

Details

This online event offers a comprehensive overview of marketing authorisation and market access in the Middle East, covering key topics like market entry, intellectual property, lifecycle management, pharmacovigilance and quality considerations, with a focus on Gulf Cooperation Council, Saudi Arabia, the UAE, Jordan and Syria.

Themen

  • Pharmaceutical marketing authorisation and market access in the GCC and key national markets
  • Intellectual property: Patents, data protection and regulatory considerations
  • Fast-track pathways, distribution strategies and legal frameworks
  • Dossier assessment, submission processes and compliance essentials
  • Key quality and production requirements for market entry
  • Import regulations, pharmacovigilance obligations and post-approval maintenance


Who should attend
This seminar is suitable for:
  • Regulatory affairs professionals in the pharmaceutical and healthcare industries
  • Market access and business development managers focusing on the Middle East region
  • Quality assurance and production specialists involved in regulatory compliance
  • Legal and intellectual property experts in the pharmaceutical sector

Participants should have a basic understanding of pharmaceutical regulatory frameworks and market access processes.

Ziel der Veranstaltung

This online training provides you with a comprehensive understanding of marketing authorisation and market access in the Middle East region, focusing on both GCC-wide and national regulatory frameworks. Through expert-led presentations and interactive discussions, you will gain in-depth knowledge of key topics such as market entry strategies, intellectual property, product classification, pricing regulations and distribution models. The event also covers legal frameworks and lifecycle management, including dossier assessments, eCTD submissions and import regulations. Additionally, it explores pharmacovigilance requirements, post-approval maintenance and quality considerations, with a particular focus on Saudi Arabia, the UAE, Jordan, and Syria.

There will be ample opportunity for individual questions, with experts on hand to provide tailored insights and guidance.

Teilnehmerkreis

  • Gain a clear overview of marketing authorisation pathways across the Middle East.
  • Develop a targeted authorisation strategy by assessing regulatory requirements and market conditions.
  • Deepen your understanding of quality, production, import regulations and eCTD dossier submissions.
Benefit from expert insights into intellectual property, pricing regulations and pharmacovigilance.
Connect with industry professionals to exchange experiences and best practices.